Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis

Journal of Hepatology

Volumn 62, Issue 1, 2016, Pages 72-74

  Turon, Fanny ^a   Cervantes, Francisco ^b   Colomer, Dolors ^b   Baiges, Anna ^a   Hernández Gea, Virginia ^a,c   Garcia Pagán, Juan Carlos ^a,c  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Calreticulin mutations; JAK2 mutations; Myeloproliferative neoplasms; Splanchnic vein thrombosis

Indexed keywords

CALRETICULIN; JANUS KINASE 2; PROTEIN C; PROTEIN S; PROTHROMBIN; CALRETICULIN, HUMAN; DNA;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BONE MARROW BIOPSY; BUDD CHIARI SYNDROME; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOID METAPLASIA; MYELOPROLIFERATIVE NEOPLASM; POLYCYTHEMIA VERA; PORTAL VEIN THROMBOSIS; PORTOSYSTEMIC ANASTOMOSIS; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RETROSPECTIVE STUDY; SOMATIC MUTATION; SPLANCHNIC VEIN THROMBOSIS; THROMBOCYTHEMIA; VEIN THROMBOSIS; COLOR DOPPLER FLOWMETRY; DNA MUTATIONAL ANALYSIS; FOLLOW UP; GENETICS; MESENTERIC VASCULAR OCCLUSION; MESENTERIC VEIN; METABOLISM; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; VENOUS THROMBOSIS;

ADULT; CALRETICULIN; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MESENTERIC VASCULAR OCCLUSION; MESENTERIC VEINS; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, DOPPLER, COLOR; VENOUS THROMBOSIS;

EID: 84918790074     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.08.032     Document Type: Article

References (10)

1. J.H. Smalberg, L.R. Arends, D.C. Valla, J.J. Kiladjian, H.L. Janssen, and F.W. Leebeek Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-Analysis Blood 120 2012 4921 4928
2. J.H. Smalberg, E. Koehler, M.S. Darwish, A. Plessier, S. Seijo, and J. Trebicka The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis Blood 117 2011 3968 3973
3. J.J. Kiladjian, F. Cervantes, F.W. Leebeek, C. Marzac, B. Cassinat, and S. Chevret The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases Blood 111 2008 4922 4929
4. A. Tefferi, and J.W. Vardiman Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms Leukemia 22 2008 14 22
5. Y. Chait, B. Condat, D. Cazals-Hatem, P. Rufat, S. Atmani, and D. Chaoui Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis Br J Haematol 129 2005 553 560
6. T. Klampfl, H. Gisslinger, A.S. Harutyunyan, H. Nivarthi, E. Rumi, and J.D. Milosevic Somatic mutations of calreticulin in myeloproliferative neoplasms N Engl J Med 369 2013 2379 2390
7. J. Nangalia, C.E. Massie, E.J. Baxter, F.L. Nice, G. Gundem, and D.C. Wedge Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2 N Engl J Med 369 2013 2391 2405
8. E.J. Baxter, L.M. Scott, P.J. Campbell, C. East, N. Fourouclas, and S. Swanton Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders Lancet 365 2005 1054 1061
9. G. Rotunno, C. Mannarelli, P. Guglielmelli, A. Pacilli, A. Pancrazzi, and L. Pieri Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia Blood 123 2014 1552 1555
10. E. Rumi, D. Pietra, V. Ferretti, T. Klampfl, A.S. Harutyunyan, and J.D. Milosevic JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes Blood 123 2014 1544 1551